|
Anthony Watkins leads Oscient's corporate development activities with a focus on further expanding the Company's product portfolio and establishing business partnerships. Mr. Watkins most recently worked as the Director of Finance and Business Development for Eli Lilly China. Prior to his role for Eli Lilly China, Mr. Watkins worked in the Corporate Finance, Investment Banking and Strategy groups for Eli Lilly at its headquarters in Indiana. During his career with Lilly, Mr. Watkins was responsible for or participated in over 50 completed discovery and technology licensing and late-stage in-licensing transactions, and directed strategic planning activities for Lilly's $3 billion endocrine business. Prior to joining Lilly in 1999, Mr. Watkins spent several years at Pfizer in a variety of strategic positions, and gained additional experience as a strategy consultant at the firm Booz Allen Hamilton. Mr. Watkins received his M.B.A. from the University of Chicago Graduate School of Business. He also holds a Master's degree in Industrial Relations and a B.S. in Mathematics and Economics, both from the University of Wisconsin-Madison. | 